A groundbreaking stem cell treatment has successfully improved vision in three out of four patients with damaged corneas. The treatment uses induced pluripotent stem cells from a healthy donor's blood cells to create transparent corneal tissue. + The clinical trial involved two women and two men, aged 39 to 72, all with a condition called limbal stem-cell deficiency in both eyes. Doctors removed scar tissue from one eye of each patient and replaced it with lab-grown corneal cells. + Three patients maintained their improved vision for over a year after the procedure. The treatment proved safe, with no tumor formation or immune system rejection—common concerns with transplants. + “These success stories suggest we are headed in the right direction,” Kapil Bharti, a translational stem-cell researcher at US National Eye Institute, commented. #Science is awesome 🧬🦾🚀🤯 https://timesofindia.indi...